| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.18 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |